OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance

By afschroeder • January 28, 2026

Bernard MJ, Gallardo A, Ruiz A, Diaz JA, Nunley NM, Dove RN, Zhang S, Lee E, Heering KY, Varuzhanyan G, Bopardikar S, Hashimoto T, Agrawal R, Smith CM, Wilde BR, Matulionis N, Richards HM, Lee SCS, Sharifi MN, Lang JM, Zhao SG, Witte ON, Haffner MC, Shackelford DB, Boutros PC, Christofk HR, Goldstein AS. OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundance. Mol Cancer Res. 2026 Jan 27. doi: 10.1158/1541-7786.MCR-25-0913. Epub ahead of print. PMID: 41591383.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Age and Sex in Breast Cancer: Moving Beyond a One-Size-Fits-All Approach

Leone JP, Sedrak MS. Age and Sex in Breast Cancer: Moving Beyond a One-Size-Fits-All Approach. Clin Breast Cancer. 2026 Apr 14;26(5):71-74. doi: 10.1016/j.clbc.2026.03.015. Epub ahead[...]

A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritis

Soowamber ML, Bond M, Sanchez-Alvarez C, Langford CA, Aydin SZ, Buttgereit F, Camellino D, Cid MC, Grayson PC, Hellmich B, Hendry A, Kermani TA, Khalidi[...]

DENND5B Disruption Results in Reduced Body Fat and Increased Intestinal Fatty Acid Oxidation by Activation of Autophagy

Neupane KR, Karakashian A, Mobilia M, Hage O, Tso P, Liu M, Vergnes L, Reue K, Gordon SM. DENND5B Disruption Results in Reduced Body Fat[...]